Dialysis Catheter Comparative Clinical Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00526123
Recruitment Status : Completed
First Posted : September 6, 2007
Results First Posted : January 7, 2013
Last Update Posted : January 7, 2013
Information provided by (Responsible Party):
Tyco Healthcare Group

Brief Summary:
The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

Condition or disease Intervention/treatment Phase
End Stage Renal Disease Device: Symmetric Tip Catheter Device: Conventional Split-tip Catheter Not Applicable

Detailed Description:
This study is a multi-center, randomized, prospective, open-label, clinical study comparing a conventional split-tip catheter and a symmetric tip catheter in subjects undergoing hemodialysis.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 599 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Open-label Comparison of the Performance and Longevity of a Split-tip Versus a Symmetric Tip Hemodialysis
Study Start Date : September 2007
Actual Primary Completion Date : August 2011
Actual Study Completion Date : August 2011

Arm Intervention/treatment
Active Comparator: 1
symmetric tip catheter
Device: Symmetric Tip Catheter
Dialysis catheter

Active Comparator: 2
conventional split-tip catheter
Device: Conventional Split-tip Catheter
Dialysis Catheter

Primary Outcome Measures :
  1. First Catheter Induced Complication [ Time Frame: 30 days ]
    % of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.

  2. First Catheter Induced Complication [ Time Frame: 60 days ]
    % of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.

  3. First Catheter Induced Complication [ Time Frame: 245 days ]
    % of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.

Secondary Outcome Measures :
  1. Inadequate Flow Rates Requiring Surgical/Radiological Intervention [ Time Frame: 35 weeks ]
    Number of events per study group in which the first catheter induced complication was 'inadequate flow requiring surgical/radiological intervention'.

  2. Average Number of Line Reversals Per Subject [ Time Frame: 35 Weeks ]
    Average number of times the dialysis lines were reversed per subject to deliver dialysis treatments

  3. Frequency of Clinician Interventions for Catheter Malfunction and Infection [ Time Frame: 35 Weeks ]
    Average number of times clinician intervention was required for either catheter malfunction or infection

  4. Primary Failure Rate [ Time Frame: First dialysis session with study catheter ]
    The percentage of catheters unable to deliver adequate blood flow of at least 300 mL/min for at least 50% of measurements during the first attempted dialysis session.

  5. Reliability of the Catheter [ Time Frame: 35 Weeks ]
    Percentage of study visits in which the median blood flow rate was greater than or equal to 300 mL/min.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Subject must be 18 years of age or older.
  • Subject must meet labeled indication for hemodialysis.
  • Subject must have End Stage Renal Disease (ESRD).
  • Subject must have a patent right or left internal jugular vein.
  • Subject treatment plan must require chronic hemodialysis treatments 3 times per week for a minimum of 6 weeks.
  • Subject must give written informed consent.

Exclusion Criteria:

  • Subjects who are concurrently enrolled in any Randomized Clinical Trial (RCT) or those that may enroll in a RCT during the course of the study, or subjects who have been previously randomized into this clinical study.
  • Subjects with active infection at the time of study enrollment.
  • Subjects with a known sensitivity to heparin, or previous incidence of heparin-induced thrombocytopenia.
  • Subjects with uncontrolled abnormal coagulation parameters and are at additional risk for clotting or excessive bleeding.
  • Subjects who are known or suspected to be pregnant at the time of study enrollment or plan to get pregnant during the study period.
  • Subjects for whom performing dialysis at flow rates up to 450 mL/min would be contraindicated for any reason.
  • Subject unable or unwilling to commit to follow-up visits and study procedures throughout the course of the study.
  • Subjects who, in the opinion of the Investigators, are not appropriate candidates for the study based upon current or past medical history, or negative past experience with either of the study catheters.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00526123

United States, Alabama
Nephrology Associates, P.C.
Birmingham, Alabama, United States, 35211
United States, Arizona
Southwest Kidney Institute
Phoenix, Arizona, United States, 85004
United States, Massachusetts
Tufts Medical Center
Boston, Massachusetts, United States, 02111
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
United States, New York
SUNY Stony Brook Medical Center
Stony Brook, New York, United States, 11794
United States, North Carolina
Eastern Nephrology Associates
Greenville, North Carolina, United States, 27834
Eastern Nephrology Associates
New Bern, North Carolina, United States, 28562
Boice-Willis Clinic
Rocky Mount, North Carolina, United States, 27804
Dialysis Access Group of Wake Forest University, LLC
Winston-Salem, North Carolina, United States, 27101
United States, Ohio
Toledo Hospital
Toledo, Ohio, United States, 43606
United States, Pennsylvania
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140
Nephrology Associates - Lankenau Hospital
Wynnewood, Pennsylvania, United States, 19096
United States, South Carolina
Columbia Nephrology Associates
Columbia, South Carolina, United States, 29203
United States, Wisconsin
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Sponsors and Collaborators
Tyco Healthcare Group
Principal Investigator: Klemens B Meyer, MD

Responsible Party: Tyco Healthcare Group Identifier: NCT00526123     History of Changes
Other Study ID Numbers: 341.26
First Posted: September 6, 2007    Key Record Dates
Results First Posted: January 7, 2013
Last Update Posted: January 7, 2013
Last Verified: January 2013

Keywords provided by Tyco Healthcare Group:
Dialysis Catheter
Kidney Disease
Dialysis Clinic
Chronic Catheter

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases